Men who became ill in drug trial improveBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7545.812-a (Published 06 April 2006) Cite this as: BMJ 2006;332:812
- Susan Mayor
Four of the six men who became seriously ill in a UK clinical trial of a monoclonal antibody, TGN1412 (BMJ 2006;332:683, 25 Mar), have been allowed to return home, the hospital that cared for them said this week.
In a statement Ganesh Suntharalingam, clinical director of intensive care at Northwick Park Hospital, London, said: “There has been continued progress amongst the patients since they were transferred here on 13 March following a drug trial.” He said that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial